Warning: Undefined array key 0 in
/var/www/hoodb/function.php on line
154
Warning: Trying to access array offset on value of type null in
/var/www/hoodb/function.php on line
154
🔥오늘의 인기 주제: lly
|
대한민국
다음은 20242021년 3월 30일 일본 네티즌들 사이에서 많은 화제와 관심을 모았던 lly 에 대한 특별한 이야기다.
lly의 핫 뉴스
Warning: file_get_contents(aCache/aaa/index/kr/-lly.txt): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
다음 웹사이트에서 빠른 검색 lly.
lly 키워드
다른 웹사이트에서도 최근에 lly 에 대한 키워드를 검색했습니다.
Warning: file_get_contents(aCache/Gkeys/kr/lly-2): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
lly에 대한 더 많은 과거 뉴스
-
일라이 릴리(LLY), 체중 감량 신약으로 미국 내 41억 달러 추가 매출 전망 - 인포스탁데일리
-
일라이 릴리(LLY) 52주 신고가 - 한국경제
-
일라이 릴리(LLY.N), 아마존(AMZN.O)과 함께 체중 감량 보조제 판매 By 알파경제 alphabiz - Investing.com
-
일라이 릴리(LLY), 포인트 바이오파마 글로벌(PNT) 14억 달러에 인수 발표 - 인포스탁데일리
-
"일라이일리(LLY), 4분기 어닝 서프라이즈..실적 고성장세 지속" By 알파경제 alphabiz - Investing.com
-
일라이릴리(LLY) 비만치료제 美 FDA 승인…”위고비 보다 성능·가격 우위” - 인포스탁데일리
-
일라이 릴리(LLY), 3분기 실적 컨센서스 소폭 상회...긍정적 주가 흐름 전망 - 인포스탁데일리
-
포인트 바이오파마 글로벌(PNT), 규제 승인에 주가 상승세…일라이 릴리(LLY) 입찰가 증가 가능성 제기 - 인포스탁데일리
-
일라이 릴리 EVP&Pres, LLY Dia&Obe, LLY 미국(officer: EVP&Pres, LLY Dia&Obe, LLY USA) 15억9333만원어치 지분 매수거래 - 한국경제
-
일라이릴리(LLY), 위고비 대비 20% 낮은 약가로 건강보험 커버리지 확대 기대 - 인포스탁데일리
-
일라이릴리(LLY), 당뇨, 항암제 부문 중심으로 성장...젭바운드 본격 판매 시작 - 인포스탁데일리
-
일라이 릴리(LLY) 수시 보고 - 한국경제
-
[GAM] 바이킹 테라퓨틱스 100% 폭등 ② LLY·NVO에 대항할 루키? - 뉴스핌
-
일라이 릴리,예상 웃돈 분기 실적에도 주가 시큰둥한 까닭은 - 연합인포맥스
-
일라이 릴리(LLY), '마운자로' 처방 증가세... 비만 치료제 '티르제파타이드' FDA 승인 전망 - 인포스탁데일리
-
일라이릴리(LLY), 올해 중 비만 적응증 획득으로 비만 치료제 선두주자 될 것 - 인포스탁데일리
-
일라이 릴리(LLY), 비만치료제 마운자로 가파른 성장세... 비만 관련 현존 최고 효력의 치료 옵션 보유 - 인포스탁데일리
-
일라이 릴리(LLY), 당뇨 치료제 '마운자로' 성장성...헬스케어 시가 총액 1위 등극 - 인포스탁데일리
-
일라이 릴리(LLY), '레타트루타이드' 동종 최고의 비만 신약 가능성 - 인포스탁데일리
-
일라이 릴리(LLY), 알츠하이머 신약 후보물질 '도나네맙' 연내 FDA 승인 예정 - 인포스탁데일리
-
비만과 알츠하이머 신약 시장 주목...'일라이 릴리(LLY)'와 '노보 노디스크(NVO)' 관심 - 인포스탁데일리
-
일라이 릴리 앤 코(LLY), 알츠하이머 치료제 '도나네맙(donanemab)' 성공적 임상 3상 결과 발표 - 인포스탁데일리
-
일라이 릴리(LLY), 당뇨 치료제 '마운자로' 수요 급증... 체중감소 효과까지 입증 - 인포스탁데일리
-
"일라이릴리(LLY), 신약 출시로 매출 증가 기대" - 인포스탁데일리
-
일라이 릴리(LLY), '마운자로' 비만 치료제로 FDA 승인 전망 - 인포스탁데일리
-
[특파원 리포트] 일라이 릴리(LLY), 메디케이드 사기 내부고발 소송 패소시 벌금 최대 1억8300만 달러 - 인포스탁데일리
-
Is Eli Lilly Stock A Buy After Weight-Loss Win In Sleep Apnea? - Investor's Business Daily
-
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
-
[특파원 리포트] 일라이 릴리(LLY), 1분기 호실적 달성..."개발 중인 신약들 3상 결과 긍정적" - 인포스탁데일리
-
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts - Yahoo Finance
-
LLY (Eli Lilly and Co) Book Value per Share - GuruFocus.com
-
LLY vs. JNJ: Which Big Pharma Stock Is Better? - TipRanks.com - TipRanks
-
Eli Lilly and Company (NYSE:LLY) Stock Holdings Lifted by Boyd Watterson Asset Management LLC OH - MarketBeat
-
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? - Yahoo Finance Australia
-
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo
-
Market Whales and Their Recent Bets on LLY Options - Eli Lilly and Co (NYSE:LLY) - Benzinga
-
Eli Lilly and Company (NYSE:LLY) is largely controlled by institutional shareholders who own 84% of the company - Yahoo
-
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo
-
LLY June 7th Options Begin Trading - Nasdaq
-
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? - Zacks Investment Research
-
Eli Lilly and Company (LLY) to Release Quarterly Earnings on Tuesday - Defense World
-
What You Can Learn From Eli Lilly and Company's (NYSE:LLY) P/S - Simply Wall St
-
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans - TipRanks.com - TipRanks
-
Eli Lilly and Co (HAM:LLY) 3-Year Book Growth Rate : 24.40% (As of Dec. 2023) - GuruFocus.com
-
Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing Plans - MSN
-
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
-
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
-
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
-
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data - Yahoo Finance
-
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue - CNBC
-
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and ... - PR Newswire
-
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies - Yahoo
-
Lilly (LLY) Partners Amazon to Deliver Drugs Like Zepbound - Yahoo Finance
-
Eli Lilly (LLY) Stock Up 57% in 2023: Will the Uptrend Continue? - Yahoo Finance
-
LLY Stock Alert: You Can Now Get Eli Lilly's Weight Loss Drugs on Amazon - InvestorPlace
-
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
-
Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors - Yahoo Finance
-
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? - MSN
-
Eli Lilly (LLY) to Report Q4 Earnings: What's in the Cards? - Yahoo Finance
-
Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
-
What Makes Eli Lilly and Company (LLY) an Attractive Investment? - Yahoo Finance
-
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
-
Eli Lilly (LLY) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
-
Why Eli Lilly (LLY) Dipped More Than Broader Market Today - Yahoo Finance
-
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts - Zacks Investment Research
-
Lilly (LLY) Up 7.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
-
Eli Lilly Stock (NYSE:LLY): Hold Off Until the End of the Month - TipRanks.com - TipRanks
-
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
-
10 things to watch in the stock market, including Eli Lilly, Amazon, Meta and Ford - CNBC
-
Eli Lilly and Company (NYSE:LLY) is Jennison Associates LLC's 5th Largest Position - MarketBeat
-
LLY, CVS, EXAS: Which Strong-Buy-Rated Healthcare Stock Is the Better Buy? - Yahoo Finance
-
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Yahoo
-
Eli Lilly and Company (NYSE:LLY) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
-
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know - Yahoo Finance
-
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Zacks Investment Research
-
How to Buy Eli Lilly Stock (LLY) - The Motley Fool
-
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
-
Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.30 - Yahoo Finance
-
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock - Yahoo Finance
-
LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer? - Yahoo Finance
-
Eli Lilly (LLY) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
-
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More - Yahoo Finance
-
Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
-
Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
-
Lilly (LLY) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
-
Eli Lilly's (NYSE:LLY) Weight-Loss Drug Outshines Wegovy for First Time - TipRanks.com - TipRanks
-
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
-
LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside? - TipRanks.com - TipRanks
-
Eli Lilly (LLY) Rises Yet Lags Behind Market: Some Facts Worth Knowing - Yahoo Finance
-
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight - Yahoo Finance
-
Eli Lilly (LLY), Novo (NOVOB DC) Risk Missing High Expectations, Goldman Says - Bloomberg
-
Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
-
More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its ... - PR Newswire
-
LLY vs NVO: Which One is Likely to Become a $1T Company First - The Tokenist
-
Eli Lilly (LLY) Stock Outperforms Industry YTD: Here's Why - Yahoo Finance
-
Pharma Stock Roundup: NVO & LLY to Expand Manufacturing Capacity in Europe, & More - Yahoo Finance
lly웹사이트에 대한 추가 정보
약 lly
Warning: file_get_contents(aCache/search/kr/lly): Failed to open stream: No such file or directory in
/var/www/hoodb/function.php on line
340
Back to Top